Malaria: Difference between revisions
From WikiDemocracy
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 191: | Line 191: | ||
[https://www.nature.com/articles/d41586-019-01232-4 by Declan Butler 16/4/19 nature] | [https://www.nature.com/articles/d41586-019-01232-4 by Declan Butler 16/4/19 nature] | ||
A malaria vaccine that can provide up to 100% protection against the disease will be tested in a large clinical trial for the first time, to study its efficacy under real-world conditions. | A malaria vaccine that can provide up to 100% protection against the disease will be tested in a large clinical trial for the first time, to study its efficacy under real-world conditions. | ||
=====Malaria Vaccines===== | |||
[https://www.cdc.gov/malaria/php/public-health-strategy/malaria-vaccines.html by public health 2/4/24 CDC] | |||
Malaria vaccines have been in development since the 1960's, with substantial progress in the last decade. October 6, 2021, marked a historic day in the development of malaria vaccines, with release of the World Health Organization (WHO) recommendation for widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children living in sub-Saharan Africa and other regions with moderate to high P. falciparum malaria transmission. Two years later, the WHO approved a second malaria vaccine (R21/Matrix-M) for use in malaria endemic countries. | |||
